Compare AAME & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AAME | BTMD |
|---|---|---|
| Founded | 1968 | 2012 |
| Country | United States | United States |
| Employees | N/A | 223 |
| Industry | Life Insurance | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.3M | 39.0M |
| IPO Year | 1995 | 2021 |
| Metric | AAME | BTMD |
|---|---|---|
| Price | $1.39 | $1.26 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $2.83 |
| AVG Volume (30 Days) | 61.9K | ★ 222.4K |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.81% | N/A |
| EPS Growth | N/A | ★ 722.22 |
| EPS | ★ 0.22 | N/A |
| Revenue | $188,227,000.00 | ★ $192,219,000.00 |
| Revenue This Year | N/A | $2.03 |
| Revenue Next Year | N/A | $6.58 |
| P/E Ratio | $5.95 | ★ N/A |
| Revenue Growth | ★ 0.77 | N/A |
| 52 Week Low | $1.25 | $1.21 |
| 52 Week High | $3.24 | $3.26 |
| Indicator | AAME | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 51.31 | 35.17 |
| Support Level | $1.26 | N/A |
| Resistance Level | $1.62 | $1.68 |
| Average True Range (ATR) | 0.06 | 0.08 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 86.66 | 11.76 |
Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.